Skip to content
10-Q

Quarterly Report

Regenerative Medical Technology Group Inc. RMTG

0001213900-25-078525

← back to feed
Filed
Aug 19, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 17, 2025 12.54M sh
Shares Diluted Q2 2025 · Jun 30, 2025 12.54M sh
Shares Diluted Q2 2025 · Jun 30, 2025 12.54M sh
Shares Diluted Q2 2025 · Jun 30, 2024 12.49M sh
Shares Diluted Q2 2025 · Jun 30, 2024 12.49M sh
Capex Q2 2025 · Jun 30, 2025 $110.58K
Capex Q2 2025 · Jun 30, 2024 $111.81K
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$540.98K
Operating Cash Flow Q2 2025 · Jun 30, 2024 $198.36K
Cash And Equivalents Q2 2025 · Jun 30, 2025 $1.61M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $1.17M
Stockholders Equity Q2 2025 · Jun 30, 2025 −$29.02M
Stockholders Equity Q2 2025 · Mar 31, 2025 −$28.12M
Stockholders Equity Q2 2025 · Dec 31, 2024 −$27.36M
Stockholders Equity Q2 2025 · Jun 30, 2024 −$25.83M
Stockholders Equity restated Q2 2025 · Mar 31, 2024 −$23.76M
Stockholders Equity Q2 2025 · Dec 31, 2023 −$21.8M
Current Liabilities Q2 2025 · Jun 30, 2025 $30.54M
Current Liabilities Q2 2025 · Dec 31, 2024 $28.97M
Total Liabilities Q2 2025 · Jun 30, 2025 $33.51M
Total Liabilities Q2 2025 · Dec 31, 2024 $31.18M
Current Assets Q2 2025 · Jun 30, 2025 $1.91M
Current Assets Q2 2025 · Dec 31, 2024 $1.25M
Total Assets Q2 2025 · Jun 30, 2025 $4.49M
Total Assets Q2 2025 · Dec 31, 2024 $3.82M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.10
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.16
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.17
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.32
Eps Basic Q2 2025 · Jun 30, 2025 −$0.10
Eps Basic Q2 2025 · Jun 30, 2025 −$0.16
Eps Basic Q2 2025 · Jun 30, 2024 −$0.17
Eps Basic Q2 2025 · Jun 30, 2024 −$0.32
Net Income Q2 2025 · Jun 30, 2025 −$1.31M
Net Income Q2 2025 · Jun 30, 2025 −$2.07M
Net Income Q2 2025 · Jun 30, 2024 −$2.08M
Net Income Q2 2025 · Jun 30, 2024 −$4.04M
Operating Income Q2 2025 · Jun 30, 2025 −$250.09K
Operating Income Q2 2025 · Jun 30, 2025 −$115.13K
Operating Income Q2 2025 · Jun 30, 2024 −$213.98K
Operating Income Q2 2025 · Jun 30, 2024 −$319.09K
Gross Profit Q2 2025 · Jun 30, 2025 $585.83K
Gross Profit Q2 2025 · Jun 30, 2025 $1.53M
Gross Profit Q2 2025 · Jun 30, 2024 $526.88K
Gross Profit Q2 2025 · Jun 30, 2024 $1.1M
Cost Of Revenue Q2 2025 · Jun 30, 2025 $397.69K
Cost Of Revenue Q2 2025 · Jun 30, 2025 $818.13K
Cost Of Revenue Q2 2025 · Jun 30, 2024 $266.45K
Cost Of Revenue Q2 2025 · Jun 30, 2024 $514.49K
Revenue Q2 2025 · Jun 30, 2025 $983.52K
Revenue Q2 2025 · Jun 30, 2025 $2.35M
Revenue Q2 2025 · Jun 30, 2024 $793.33K
Revenue Q2 2025 · Jun 30, 2024 $1.61M